Brain-computer interface based on Rice research wins FDA approval for first clinical trial
April 28, 2026
April 28, 2026
HOUSTON, Texas, April 28 -- Rice University posted the following news release:
* * *
Brain-computer interface based on Rice research wins FDA approval for first clinical trial
*
Motif Neurotech, a company commercializing technology based on research at Rice University, has received approval from the U.S. Food and Drug Administration to begin the first clinical trial of its therapeutic brain-computer interface (BCI) for treatment of treatment-re . . .
* * *
Brain-computer interface based on Rice research wins FDA approval for first clinical trial
*
Motif Neurotech, a company commercializing technology based on research at Rice University, has received approval from the U.S. Food and Drug Administration to begin the first clinical trial of its therapeutic brain-computer interface (BCI) for treatment of treatment-re . . .